tiprankstipranks
Trending News
More News >
Hofseth Biocare ASA (HOFBF)
OTHER OTC:HOFBF
US Market

Hofseth Biocare ASA (HOFBF) Income Statement

Compare
6 Followers

Hofseth Biocare ASA Income Statement

Last quarter (Q4 2025), Hofseth Biocare ASA's total revenue was kr71.14M, an increase of 9.49% from the same quarter last year. In Q4, Hofseth Biocare ASA's net income was kr-48.27M. See Hofseth Biocare ASA’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
kr 254.43Mkr 257.42Mkr 194.87Mkr 120.45Mkr 87.62M
Gross Profit
kr -32.47Mkr 87.86Mkr 44.19Mkr 28.51Mkr 23.10M
Operating Expenses
kr 80.22Mkr 96.47Mkr 146.72Mkr 157.13Mkr 141.66M
Depreciation and Amortization
kr 39.41Mkr 34.12Mkr 36.41Mkr 30.22Mkr 29.35M
EBITDA
kr -73.28Mkr -68.01Mkr -62.73Mkr -97.01Mkr -87.72M
Operating Income
kr -112.69Mkr -113.98Mkr -102.53Mkr -128.62Mkr -118.56M
Other Income/Expenses
kr -22.02Mkr -11.31Mkr -4.16Mkr -8.77Mkr -7.90M
Pretax Income
kr -134.71Mkr -125.30Mkr -106.68Mkr -137.39Mkr -126.46M
Net Income
kr -134.88Mkr -123.41Mkr -106.68Mkr -137.39Mkr -126.46M
Per Share Metrics
Basic EPS
kr -0.33kr -0.30kr -0.27kr -0.37kr -0.35
Diluted EPS
kr -0.33kr -0.30kr -0.27kr -0.37kr -0.35
Weighted Average Shares Outstanding
411.08M 411.08M 395.08M 374.74M 357.83M
Weighted Average Shares Outstanding (Diluted)
411.08M 412.17M 395.08M 374.74M 357.83M
Currency in NOK

Hofseth Biocare ASA Earnings and Revenue History